Please join us for the 2013 Biotech at the Breakers breakfast featuring the Scripps Research Institute, Max Planck Institute, Vaccine & Gene Therapy of Florida (VGTI) and Torrey Pines Institute for Molecular Studies (TPIMS).
FRIDAY NOVEMBER 8 - 8 AM TO 9:30 AM
These four world renowned bioscience research institutes, along with the Florida research universities, are creating technologies that can change medical science through their spin-out companies and firms that can commercialize their research. Join us on November 8 to hear the third annual PBBG semi-public "Report" by these four institutes on their progress and their science. You can also meet some of the early stage companies active in the South Florida bioscience arena.
The 2013 Biotech Breakfast at the Breakers features, from the Scripps Research Institute - Dr. Patrick Griffin, Professor and Chair of Molecular Therapeutics, and Director and Head of the Translational Research Institute at The Scripps Research Institute, Scripps FLorida, from Max Planck Institute - Dr. Matthias Haury, Chief Operating Officer, from the Vaccine & Gene Therapy of Florida (VGTI) - Douglas W. Calder, Director of Strategic Development, and from the Torrey Pines Institute for Molecular Studies - Dr. Gregg Fields, VP of Scientific Affairs.They will be reporting upon their accomplishments to date, including some of the new scientific developments that could lead to the treatment and/or cure of diseases. Please see the website for speaker biographies.
A powerful Philanthropic Panel is being added to emphasize the need for local philanthropic support due to reduced federal research funding. This panel is composed of Ambassador Nancy Brinker, Chairman of the Komen Foundation (Race for the Cure), William Meyer, Chairman of the Quantum Foundation, and William Koch, CEO of Oxbow Inc., a major worldwide energy company.